| Assessment Status | Rapid Review Complete |
| HTA ID | - |
| Drug | Asenapine |
| Brand | Sycrest® |
| Indication | For the treatment of moderate to severe manic episodes associated with biopolar 1 disorder in adults. |
| Assessment Process | |
| Rapid review commissioned | 17/08/2011 |
| Rapid review completed | 06/09/2011 |
| Rapid review outcome | Full Pharmacoeconomic Evaluation not Recommended |